How Long Can You Bleed With Fibroids?

Fibroid-related bleeding can persist for months or even years if left untreated, and in many cases it does not resolve on its own before menopause. Research tracking women with symptomatic fibroids who received no active treatment found that excessive menstrual bleeding remained essentially stable over nearly ten months of observation, with the volume of blood loss at the end barely budging from where it started.¹ That finding undercuts a common hope that fibroid bleeding will simply “settle down.” How long it actually lasts depends on the fibroid’s size, location, and your body’s ability to compensate for chronic blood loss, but the short version is that waiting it out without any intervention is rarely a strategy that works.

Why Fibroids Cause Heavy and Prolonged Bleeding

Fibroids are not just inert lumps of muscle tissue sitting in the uterus. They actively change the local blood supply and the way the uterine lining functions. Roughly a third of people with fibroids develop heavy menstrual bleeding, and more than half experience at least one major symptom such as heavy periods, pelvic pain, or fertility problems.² Several overlapping mechanisms explain why bleeding gets so heavy and why it tends to drag on.

First, fibroids alter the blood vessel network in and around the uterus. The genetic mutations that drive fibroid growth also ramp up the production of growth factors that stimulate new blood vessel formation. This process differs from how blood vessels grow in other contexts and creates an abnormal vascular network that bleeds more freely when the uterine lining sheds each month.² Second, fibroids interfere with the uterus’s natural ability to stop bleeding. Normally, the uterine muscle contracts after menstruation to clamp down on open blood vessels, and the endometrium produces substances that help blood clot locally. Fibroids disrupt both of these defenses: they reduce the production of local clotting factors and shift the balance of chemicals that constrict blood vessels, resulting in heavier and longer periods.³

The practical effect is that your period may last well beyond the typical range, sometimes stretching past a week, and the flow itself is often far heavier than normal. Some people also bleed between periods. Because the fibroid is a structural problem that does not fix itself, these changes tend to persist cycle after cycle until the fibroid is treated or until hormonal shifts at menopause reduce its blood supply.

What Untreated Bleeding Looks Like Over Time

One of the clearest pictures of untreated fibroid bleeding comes from the placebo arm of a clinical trial where women with confirmed heavy bleeding from fibroids received no active drug. At the start of the study, the median blood loss score was 376 on a standardized scale where anything above 100 is considered excessive. Over the next several menstrual cycles, that score barely moved, hovering at roughly 90 to 93 percent of the initial value from one period to the next. Even at 26 weeks and 38 weeks of follow-up, median scores remained in the range of 236 to 312, still well above the threshold for excessive bleeding.¹

In other words, nearly ten months of observation showed no meaningful improvement. About four in five of those women had regular cycles throughout, so the issue was not chaotic or unpredictable bleeding but a reliable, punishingly heavy period returning every month. This is the trajectory many people experience: not a dramatic acute bleed that resolves, but a chronic drain that gradually wears the body down.

When Chronic Bleeding Becomes Dangerous

The biggest medical risk of prolonged fibroid bleeding is iron-deficiency anemia. Losing too much blood each cycle means your body cannot replace red blood cells fast enough. Common symptoms of the resulting anemia include fatigue, weariness, dizziness, and shortness of breath. A cross-sectional survey found that fatigue and weariness affected about 63 percent of women with symptomatic fibroids, and the more symptoms a person had, the worse their overall quality of life scores became.⁴

In severe cases, the anemia can become life-threatening. Case reports describe women arriving at emergency departments with hemoglobin levels below 2 g/dL, dangerously close to fatal levels. One 34-year-old arrived with a declining level of consciousness after years of heavy periods she had never sought treatment for; she had a five-centimeter submucosal fibroid. Another 36-year-old presented with progressive difficulty breathing and a hemoglobin of just 1.7 g/dL. A third patient, age 49, came in with severe abdominal pain and a hemoglobin of 1.9 g/dL.⁵ An even more extreme case documented a hemoglobin of 1.4 g/dL from fibroid-related bleeding, complicated by acute heart dysfunction that fortunately reversed after treatment.⁶

These cases are extreme, but they illustrate what happens at the far end of a long delay in treatment. Normal hemoglobin for an adult woman is roughly 12 to 16 g/dL, so values under 2 represent a slow-motion crisis that built up over months or years. The common thread was that each person had been bleeding heavily for a long time but had not received treatment, whether because of lack of access, normalization of heavy periods, or other barriers. The lesson is that fibroid bleeding that persists and is heavy enough to leave you consistently exhausted or short of breath warrants prompt medical evaluation, not a wait-and-see approach.

How Fibroid Location Affects Bleeding Severity

Not all fibroids bleed equally. Where a fibroid sits in the uterus matters more than its absolute size when it comes to bleeding. Submucosal fibroids, which grow into the uterine cavity and distort the lining directly, are the worst offenders. They press against the endometrium, disrupt its blood supply, and physically enlarge the surface area that sheds during a period. Even a small submucosal fibroid can cause disproportionate bleeding.

Intramural fibroids, which grow within the muscular wall, can also cause heavy periods when they are large enough to deform the cavity. Subserosal fibroids, which project outward from the uterus, are the least likely to cause bleeding problems, though they can cause other symptoms like pelvic pressure or urinary frequency. This distinction matters for treatment planning: a person with a single submucosal fibroid and a person with multiple subserosal fibroids may have very different bleeding profiles despite both having a diagnosis of “fibroids.”

Getting the Right Diagnosis

Standard transvaginal ultrasound is the usual first step when heavy bleeding prompts a visit to the doctor. It can identify most fibroids, but it is not always enough to clarify whether a fibroid is submucosal or to rule out other causes of bleeding like polyps. When ultrasound results are unclear, a saline infusion sonogram can sharpen the picture. This involves introducing a small amount of sterile saline into the uterus during the scan, which separates the walls of the cavity and makes it easier to see what is inside.

Studies have found that adding saline infusion to a standard ultrasound improved the overall sensitivity for detecting uterine abnormalities from about 67 percent to 87 percent, while also raising the negative predictive value, meaning the test became better at confirming that nothing abnormal was there.⁷ For submucosal fibroids specifically, the technique showed a sensitivity approaching 90 percent and perfect specificity in one study.⁸ Saline infusion sonography is generally recommended as a second-line test when the initial ultrasound does not give a complete answer.⁹

The reason diagnosis matters for the “how long will I bleed” question is that treatment decisions hinge on knowing exactly what type of fibroid you have and where it is. A person whose bleeding is caused by a single submucosal fibroid may need a very different intervention than someone with several intramural fibroids scattered through the uterine wall.

Medical Treatments That Reduce Bleeding

If your goal is to reduce bleeding without surgery, several medication options exist. They do not cure fibroids, but they can bring monthly blood loss down to manageable levels and buy time, whether you are planning a future procedure or approaching menopause.

Tranexamic acid is a non-hormonal medication that helps blood clot more effectively. It is taken during the heavy days of your period rather than continuously. In clinical trials, it reduced menstrual blood loss compared with placebo across multiple treatment cycles, and the reduction was actually more pronounced in women who had fibroids than in those who did not.¹⁰ A systematic review noted that while tranexamic acid can reduce bleeding from fibroids, results may vary depending on fibroid size and location.¹¹

On the hormonal side, combination therapies that suppress ovarian hormone production while adding back low-dose estrogen and a progestin have shown strong results. A large trial of relugolix combination therapy found significant improvements compared with placebo in measures of menstrual blood loss, pain, distress from bleeding and pelvic discomfort, and anemia. Some participants achieved amenorrhea, meaning their periods stopped entirely while on the medication.¹² Hormonal IUDs (the levonorgestrel type) are another commonly used option that can thin the uterine lining and substantially reduce monthly flow, though their effectiveness depends on the fibroid not distorting the cavity too much for the device to sit properly.

Procedures That Stop Bleeding Without Removing the Uterus

When medications are not enough or you want a longer-lasting solution, several procedures can address fibroids while preserving the uterus.

Uterine artery embolization (UAE) is a minimally invasive procedure performed by an interventional radiologist. It works by blocking the blood supply to the fibroid, causing it to shrink. Results have been consistently favorable for controlling bleeding. One prospective study reported that 86 percent of patients who underwent UAE experienced cessation of abnormal bleeding.¹³ Another study found that 96 percent of patients reported reduced bleeding at follow-up, along with improvements in pain and bulk symptoms.¹⁴ A separate series confirmed that heavy menstrual bleeding improved in over 90 percent of cases.¹⁵ Recovery is usually faster than surgery, typically a week or so of cramping and fatigue.

Myomectomy, the surgical removal of the fibroid itself while leaving the uterus intact, is another major option, particularly for people who want to become pregnant later. It can be done through a hysteroscope (for submucosal fibroids that are accessible through the cervix), laparoscopically, or through an open incision depending on fibroid size and number. Myomectomy is an especially important option for anyone hoping to preserve fertility.¹⁶ The trade-off is that fibroids can recur after myomectomy, sometimes within a few years, potentially requiring further treatment.

Hysterectomy, the removal of the uterus itself, is the definitive solution. It eliminates any possibility of fibroid recurrence and stops all uterine bleeding permanently. Quality-of-life studies show that patients report significant improvement one year after either hysterectomy or myomectomy, though hysterectomy patients tended to report slightly higher quality-of-life scores.¹⁷ Among women whose fibroid bleeding had progressed to anemia, hysterectomy rates were considerably higher: close to 38 to 41 percent in cohorts where heavy menstrual bleeding and fibroids co-existed, compared with about 13 percent in those with fibroids alone who did not have significant bleeding.¹⁸ This suggests that the longer and heavier the bleeding continues, the more likely a definitive surgical option becomes necessary.

Emergency Bleeding From Fibroids

While most fibroid bleeding is chronic and gradual, acute hemorrhage can happen. Submucosal fibroids in particular can cause sudden, severe vaginal bleeding that requires emergency care. Case reports have documented life-threatening acute hemorrhage from fibroids that did not respond to standard measures like IV fluids and medications, requiring emergency arterial embolization and multiple blood transfusions to stabilize the patient.¹⁹ These situations are uncommon but underscore why persistent heavy bleeding should not be normalized. If you are soaking through a pad or tampon every hour for several consecutive hours, passing large clots, or feeling lightheaded and weak, that warrants an emergency room visit, not a wait until your next scheduled appointment.

What Happens at Menopause

One of the most common questions people have is whether menopause will solve the problem. The answer is generally yes, but the timeline can be frustrating. Fibroids depend on estrogen and progesterone to grow, so when ovarian hormone production drops at menopause, fibroids tend to shrink and bleeding eases. Natural regression of fibroids begins during the menopausal transition.²⁰

The catch is perimenopause, the years leading up to menopause when hormone levels fluctuate unpredictably. During this time, abnormal uterine bleeding is extremely common and accounts for up to 70 percent of all gynecological visits in perimenopausal and postmenopausal women.²⁰ Perimenopause can last anywhere from a few years to over a decade, and for someone already dealing with fibroid bleeding, it can mean a long stretch of worsening or unpredictable symptoms before things finally improve. Relying on menopause as a treatment plan makes the most sense if you are already in your late 40s and showing signs of the transition, but it is a harder sell for someone in their mid-30s facing another 15 or more years of heavy periods.

The Impact on Daily Life

The toll of prolonged fibroid bleeding extends well beyond the physical. A U.S. survey found that the most commonly reported symptoms among women with fibroids were lower back pain (65 percent), fatigue (63 percent), pelvic cramping during periods (63 percent), bloating (61 percent), and heavy menstrual bleeding (54 percent). Women who rated their symptoms as severe had dramatically worse quality-of-life scores than those with mild or moderate symptoms, and the more symptoms a person experienced simultaneously, the worse their overall well-being.⁴

People living with heavy fibroid bleeding describe planning their lives around their periods: avoiding travel, skipping work, wearing dark clothing, doubling up on menstrual products, and sleeping on towels. The fatigue from chronic anemia compounds the problem, making it hard to exercise, concentrate, or maintain energy throughout the day. This is not a minor inconvenience. The combination of bleeding and its downstream effects can reshape a person’s social and professional life for years.

Racial Disparities in Fibroid Burden and Care

Fibroid disease does not affect all groups equally. Black women in the United States experience higher rates of fibroids, develop them at younger ages, and tend to have more severe symptoms compared with white women. A systematic review found that these disparities extend beyond biology into the healthcare system itself: Black women with fibroids experience worse clinical and surgical outcomes, which researchers linked to differential exposure to suspected environmental risk factors, lack of adequate access to care, limited access to highly skilled gynecological surgeons, and bias and discrimination within healthcare settings.²¹

This matters practically because it means the answer to “how long can you bleed with fibroids” is partly a question about access. Someone with good insurance and a responsive doctor may get diagnosed and treated within months. Someone facing systemic barriers may bleed for years before receiving effective treatment, increasing the risk of severe anemia and the likelihood of eventually needing hysterectomy rather than a less invasive option.

Fibroids and Bleeding During Pregnancy

Fibroids add a layer of risk during pregnancy, and bleeding is one of the main concerns. The location of the fibroid relative to the placenta matters enormously. When the placenta implants close to a fibroid, bleeding in early pregnancy occurs in about 60 percent of cases, compared with roughly 9 percent when the placenta and fibroid are not in contact.²² Most small fibroids do not cause major pregnancy complications, but larger ones, particularly those located in the lower uterine segment or near the placental site, may increase the risk of miscarriage, preterm delivery, and the need for cesarean section. If you have known fibroids and are pregnant or planning to become pregnant, early ultrasound to map the relationship between fibroid and placenta is standard practice.

Treatment options during pregnancy are limited because surgery carries its own risks to the pregnancy. Management is usually conservative: monitoring with ultrasound, treating pain if the fibroid degenerates (a common occurrence when a growing fibroid outstrips its blood supply), and watching for complications. The good news is that most pregnancies with fibroids reach term, but the presence of fibroids does warrant closer surveillance than a fibroid-free pregnancy.

1
Oxford Academic (Human Reproduction). Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo
2
PubMed Central. Uterine Fibroids (Leiomyomata) and Heavy Menstrual Bleeding
3
PubMed Central. Literature Review on the Role of Uterine Fibroids in Endometrial Function
4
PubMed. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey
5
PubMed Central. Life-threatening anemia due to uterine fibroids: A case series
6
PubMed Central. Severe Anemia (1.4 g/dL) Due to Uterine Fibroid Bleeding With Reversible Myocardial Dysfunction: A Case Report
7
PubMed. An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology
8
PubMed. Transvaginal sonography and saline infusion sonohysterography in the evaluation of abnormal uterine bleeding
9
PubMed Central. Diagnostic value of three-dimensional saline infusion sonohysterography in the evaluation of the uterus and uterine cavity lesions
10
PubMed. Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids
11
PubMed Central. Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence
12
PubMed Central. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy
13
PubMed. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment–a prospective, randomized, and controlled clinical trial
14
Acta Radiologica. Uterine artery embolization of symptomatic uterine fibroids: Initial success and short-term results
15
PubMed Central. Clinical Efficacy and Complications of Uterine Artery Embolization in Symptomatic Uterine Fibroids
16
Cochrane Database of Systematic Reviews. Interventions for minimising perioperative haemorrhage during myomectomy
17
PubMed. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids
18
AJOG Global Reports. Burden of anemia in women with uterine fibroid-associated heavy menstrual bleeding
19
American Journal of Roentgenology (AJR). Emergency selective arterial embolization for control of life-threatening hemorrhage from uterine fibroids
20
PubMed Central. Uterine fibroids in menopause and perimenopause
21
PubMed Central. Racial disparities in uterine fibroids and endometriosis: a systematic review and application of social, structural, and political context
22
PubMed Central. Contemporary Management of Fibroids in Pregnancy